At our recent conference Genomic Analysis in Tort Cases, panelists presented examples of results in “environmental cases” in which genomic analyses was used to provide objective evidence to trace sources of exposure and dispersal, and uses of genomic analyses for cancer cluster cases. The panel provided the perspective that genomics are well-suited to the injuries […]

At our recent conference Genomic Analysis in Tort Cases, Michael Zapata III and Leonel van Zyl, PhD provided an in depth review and analysis of the nuts and bolts for using genomic analysis in legal cases. Michael and Dr. van Zyl explained their systematic and gated methodology for helping clients considering whether a genomic approach […]

At our recent conference Genomic Analysis in Tort Cases, panelists addressed the use of genomics in medical cases (birth defects, malpractice, drugs). The panel was composed of an attorney, a medical doctor, and a genetic scientist. Dr. van Zyl, the genetic scientist, provided insightful information as to why individual genetic variability matters, including for Absorption, […]

On Tuesday April 27, Kirk Hartley of ToxicoGenomica presented a webinar hosted by the American Society for Cellular and Computational Toxicology (ASCCT). The topic was: Legal and Policy Considerations in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment. A recording of the webinar can be accessed here and a complimentary copy of […]

It is unusual when a younger person (e.g. under age 50) develops a cancer or other disease or condition that might take their life. In some instances, those situations result in lawsuits involving claims that the cancer or other disease was caused by exposure to a “toxin.” Some of the many issues that may arise […]